Some of the crucial pathological conditions of AMD were stimulated on human retinal cells (oxidative stress, inflammation, and VEGF secretion) and exposed to different concentrations of TA and QCN both individually and in combination, in an attempt to investigate their potential for the treatment of AMD. This evidence concerns the gene VEGFA and age-related macular degeneration.